REaCT-vascular Access Her2 Negative Vascular Access Strategies for (Neo) Adjuvant Breast Cancer Treatment Without Trastuzumab
NCT02688998
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Cancer
Interventions
DEVICE:
venous access PORT or PICC
Sponsor
Ottawa Hospital Research Institute